BIIB Rachid Izzar sells $300K worth of shares
Jul 17, 2025, 4:32 AM
0.00%
What does BIIB do
Biogen, headquartered in Cambridge, Massachusetts, specializes in therapies for neurological diseases, employing 7,570 people and offering treatments for conditions like MS, SMA, Alzheimer's, and ALS. Their product portfolio includes TECFIDERA, SPINRAZA, and collaborations on LEQEMBI and others.
Rachid Izzar sold 2,223 shares of BIIB on 8 July at $135.00 per share, worth a total of $300K. They now own 6,330 BIIB shares, or a 26% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.